| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7514291 | International Journal of Drug Policy | 2013 | 6 Pages |
Abstract
Provision of buprenorphine-naloxone in Finnish community pharmacies has remained relatively small-scale. As experiences have been generally positive and problems rare, it may be possible to expand these services.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Hanna Uosukainen, J. Simon Bell, Kirsti Laitinen, Ulrich Tacke, Jenni Ilomäki, Juha H.O. Turunen,